Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The nematode L-type acetylcholine receptor (L-AChR) is a ligand-gated ion channel found at the neuromuscular junctions of nematodes. It mediates excitatory neurotransmission and is a primary target for several anthelmintic drugs, notably levamisole and pyrantel. The L-AChR is pharmacologically distinct from other nicotinic acetylcholine receptor (nAChR) subtypes in nematodes. The functional L-AChR is a pentamer composed of five different subunits: three α-subunits (unc-38, unc-63, lev-8) and two non-α-subunits (unc-29, lev-1). Assembly and trafficking of this receptor require three ancillary proteins: RIC-3, UNC-50, and UNC-74. Activation leads to depolarization of muscle cells resulting in contraction. Resistance to these drugs often maps genetically to mutations or deletions in one or more of the five core subunit genes or ancillary protein genes required for proper assembly/functioning of the receptor complex.
Agonist-induced ion channel opening leading to muscle cell depolarization and contraction (Levamisole, Pyrantel). Allosteric Inhibition (Nicotine)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acetylcholine Receptor, Nematode Type L (L-AChR).